You are here

U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.

Primary tabs

Mon, 2025-05-19 08:42 — mike kraft

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk | CNN After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness. Katherine Dillinger CNN

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 0.420 seconds.